Pharmacotherapy for leptomeningeal disease in breast cancer

R Bartsch, KJ Jerzak, L Larrouquere, V Müller… - Cancer Treatment …, 2023 - Elsevier
Clinical data supporting the best therapeutic approach in leptomeningeal disease (LMD;
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …
被引用次数：2 相关文章
[HTML] cancertreatmentreviews.com

[HTML][HTML] Pharmacotherapy for leptomeningeal disease in breast cancer

R Bartsch, KJ Jerzak… - Cancer …, 2024 - cancertreatmentreviews.com
Clinical data supporting the best therapeutic approach in leptomeningeal disease (LMD;
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …

Pharmacotherapy for leptomeningeal disease in breast cancer

R Bartsch, KJ Jerzak, L Larrouquere… - Cancer treatment … - pubmed.ncbi.nlm.nih.gov
Clinical data supporting the best therapeutic approach in leptomeningeal disease (LMD;
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …

Pharmacotherapy for leptomeningeal disease in breast cancer.

R Bartsch, KJ Jerzak, L Larrouquere… - Cancer Treatment …, 2023 - europepmc.org
Clinical data supporting the best therapeutic approach in leptomeningeal disease (LMD;
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …